glp-1 and migraines Drug Cuts Migraine Days in Half A new study finds that the diabetes drug liraglutide significantly reduced monthly migraine days in patients with obesity chronic migraine. Participants reported an average Migraines and GLP-1 Medications, according
Description
Teasing out the different mechanisms at play and the subsequent effects on dementia risk is going to take a while
The goal is steady, sustainable progress, not a quick fix
Keep a sharps bin nearby so you can safely dispose of your needle afterwards
Potential side effects of GLP-1s include nausea, vomiting, changes in vision, low blood sugar, and, in rare cases, thyroid cancer
How is the food industry responding to the rise of GLP-1s like Ozempic or Mounjaro
Direct demonstration of brain insulin resistance in Alzheimers and Parkinsons disease dementia and its alleviation with incretin receptor agonists
